Molecular Oncology

SEP 7, 2026 · REVIEW

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology

A systematic review synthesizing evidence on biomarkers for BCG therapy prediction in bladder cancer; provides a landscape assessment rather than a new empirical result, identifying gaps and promising directions for clinical practice.

SEP 7, 2026 · JOURNAL ARTICLE

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology

Observational microbiota profiling study in a single cohort showing modest associations with survival outcomes, lacking a control group and powered only to detect compositional differences, not clinical prediction.

SEP 7, 2026 · JOURNAL ARTICLE

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA ‐seq datasets

Molecular Oncology

Meta-analysis of public transcriptomic data identifying candidate biomarkers and immune signatures associated with neoadjuvant response in rectal cancer, but without clinical validation, prospective design, or outcome prediction model.